Genio Technologies retweeted
Collaborative work from the Eberlin lab @livia__se describes a new design of the MasSpec Pen technology integrated to electrospray ionization (ESI) for direct analysis of nasopharyngeal swabs for COVID-19 screening. pubs.acs.org/doi/10.1021/acs…
Genio Technologies retweeted
A huge effort and international collaboration 🍾! This was such an exciting project to work on
Collaborative work from the Eberlin lab @livia__se describes a new design of the MasSpec Pen technology integrated to electrospray ionization (ESI) for direct analysis of nasopharyngeal swabs for COVID-19 screening. pubs.acs.org/doi/10.1021/acs…
Genio Technologies retweeted
Great day for #surgicalinnovation @MDAndersonNews #oncsurgery and @EberlinLab with start of our #MasSpecPen protocol in #ovariancancer surgery! #endcancer @AnilSoodMD @ShannonWestin @RossFH @HanTCun @karenluMD @drjustinbird @sgswisher
Genio Technologies retweeted
Now published as a peer-reviewed article at @Clin_Chem_AACC, our feasibility study showing translation of the MasSpec Pen to the operating room. Incredible amount of work went into this study, proud of the team that made it possible! academic.oup.com/clinchem/ad…
Genio Technologies retweeted
Groundbreaking news involving Genio Technologies & its MasSpec Pen diagnostic tool. The scientific publication, Futurity, reported MasSpec Pen system has been tested for the first time with positive results in pancreatic cancer patients during surgery. bit.ly/3r9mfpj
Genio Technologies retweeted
Groundbreaking news involving Genio Technologies & its MasSpec Pen diagnostic tool. The scientific publication, Futurity, reported MasSpec Pen system has been tested for the first time with positive results in pancreatic cancer patients during surgery. bit.ly/3r9mfpj
Genio Technologies retweeted
A diagnostic tool called the MasSpec Pen has been tested for the first time in pancreatic cancer patients during surgery to identify margins between healthy and cancerous tissue, which can help give pancreatic cancer patients a greater chance of survival. buff.ly/3AEzeUl
Genio Technologies retweeted
From our incredible collaborator, surgeon @GeorgeVanBuren, “The MasSpec Pen technology opens the door for real time, precision medicine to be performed in the operating room at a level that has never been seen before.” news.utexas.edu/2021/07/05/m…
Genio Technologies retweeted
Excited to collaborate with our colleagues at UT Austin on improving pancreas cancer care @EberlinLab @jsuliburk @BCM_Surgery @BCM_CancerEd @BCMCancerCenter @CHI_Updates @qualitybslmc – at West University Place, TX
From our incredible collaborator, surgeon @GeorgeVanBuren, “The MasSpec Pen technology opens the door for real time, precision medicine to be performed in the operating room at a level that has never been seen before.” news.utexas.edu/2021/07/05/m…
Genio Technologies retweeted
Proud to be a Texas Longhorn and collaborate with @UTAustin on the treatment of pancreas cancer. Hook Em @EberlinLab @UTAustin @BCM_Surgery @BCMCancerCenter @jsuliburk @williamefisher @PanCAN @PancanHouston @NatPancFdn – at West University Place, TX
The MasSpec Pen was tested for the first time in pancreatic cancer patients during surgery and it accurately identified tissues and surgical margins. The team from @UTAustin and @BCMFromtheLabs report results in @PNASNews. cns.utexas.edu/news/masspec-… @livia__se, @UTChemistry
Genio Technologies retweeted
We are so excited to share our first diagnostic results from testing the MasSpec Pen in pancreatic cancer surgery at @bcmhouston in our latest article, out now in @PNASNews ! @jsuliburk @GeorgeVanBuren @williamefisher pnas.org/content/118/28/e210…
Genio Technologies retweeted
The CPRIT-supported MasSpec Pen from @livia__se at @TexasScience is showing promise in pancreatic cancer surgery. Dr. Eberlin has received $2.3 million in CPRIT grants that have contributed to the development of this innovative device. Read more here: cprit.us/3wlUjQ3
Genio Technologies retweeted
Our portfolio company, Genio Technologies, celebrates another use of its MasSpec Pen System as a potential tool for fast COVID-19 screens. Read the article about the study in the health science publication, medRxiv.
@GenioTech_io
medrxiv.org/content/10.1101/…
Genio Technologies retweeted
A Mass Spec in every OR is a pretty awesome future to look forward to!
WE ARE BACK IN THE OR! After an unfortunate pause due to covid19 restrictions, our team is back in the OR testing the MasSpec Pen in cancer surgeries! Amazing effort from our research and clinical team! Go mass spec! #masspecpen #cancersurgery @jsuliburk @BCM_Surgery
Genio Technologies retweeted
Originally invented to identify cancerous tissue in people, this incredible device from @TexasScience can also now be used to determine the identity of meat and fish products in around 15 seconds: utex.as/2RheTlJ
Genio Technologies retweeted
Happening tomorrow (April 28) at noon! VICB Seminar featuring Livia Eberlin (@EberlinLab), University of Texas at Austin: "Advancing Cancer Research and Patient Care with Mass Spectrometry Technologies"
12:15 P.M. — 1:15 P.M. Zoom
Genio Technologies retweeted
Comer learn about current & future #massspec technologies on the day 3 of ACS Measurement Science Symposium (June 24). Lectures begin at 2 pm EDT. Register for free! We repeat, FOR FREE! Talks from
@livia__se
, Jennifer Brodbelt, John McLean
@hecklab
,
@JoeLoo85614818
Genio Technologies retweeted
Replying to @TailwindApp
@TailwindApp @GenioTech_io @exaptive @SendaRideNow @WhiteboardCRM @SpiersNT @thehappilyco @TenNineTech @ProgentecDx @Zero_Card Congrats on being featured in our 2021 Best Tech Startups in Oklahoma! thetechtribune.com/9-best-te…
Genio Technologies retweeted
Dr. James Willson, #CPRIT Chief Scientific Officer, will moderate "Science Sparks: Big Strides in Fighting Cancer" with Nobel Laureate Dr. James Allison of @MDAndersonNews and @livia__se of @TexasScience at the #TXScienceFest next Tuesday 3/9. For details: cprit.us/3rm9rLM
Genio Technologies retweeted
Honored to say the least! Thank you @TexasScience @CPRITTexas @EberlinLab. Can't wait! #masspecpen ✍️#cancerresearch
Dr. James Willson, #CPRIT Chief Scientific Officer, will moderate "Science Sparks: Big Strides in Fighting Cancer" with Nobel Laureate Dr. James Allison of @MDAndersonNews and @livia__se of @TexasScience at the #TXScienceFest next Tuesday 3/9. For details: cprit.us/3rm9rLM





























